Residency  >  Clinical Programs  >  Division of Neuro-Oncologic Neurosurgery and Stereotactic Radiosurgery  >  Facilities  >  Varian 600SR LINAC

Our unit was installed and became operational in October of 1994, and we have treated over 600 patients with intracranial lesions on this unit. This unit represents the first world commercial installation of its kind based on a prototype developed by the Varian Corporation in collaboration with the Joint Center for Radiation Therapy at Harvard University and the Radionics Corporation.


In the case of radiosurgery utilizing X-Knife, mastery of radiobiological principles must precede the practice of radiosurgery, since any one of an array of techniques ranging from single fraction SRS to conventional fraction SRT might be best suited for an intracranial lesion. Since radiobiological models, for example, ascribe a direct relationship between late normal tissue damage and dose per treatment delivered to these tissues10, 11, recent published series from a growing number of institutions including our own have explored the use of LINAC-based SRT for the treatment of benign tumors such as acoustic tumors. Although this experience is smaller and more recent, SRT data reflect comparable tumor control rates, and higher rates of cranial nerve preservation, most notably hearing preservation12-14.

At our institution we have established a stereotactic radiosurgery program which includes the use of a LINAC designed for and dedicated to SRS and SRT, the Varian 600SR15. Recognizing that most institutions have general purpose LINACS, we will describe our experience utilizing both techniques which should be generally applicable to the typical practice of SRS and SRT, and include case treatments as examples of each.